Axa
CLVT icon

Axa’s Clarivate CLVT Stock Holding History

Axa’s Portfolio CLVT Stock Details CLVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-271,807
Closed -$1.17M – 274
2025
Q2 		$1.17M Hold
271,807
– – ﹤0.01% 866
2025
Q1 		$1.07M Buy
+271,807
New +$1.29M ﹤0.01% 834

Other funds holding CLVT

LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.38B AUM 6.22% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return

Axa's CLVT Position: Q3 2025 in Review

Axa sold out of Clarivate (CLVT) in Q3 2025, closing a stake of 271,807 shares — an estimated $1.17M sold.

Axa first reported a position in CLVT in Q1 2025 and held it in 2 quarters. The position peaked at $1.17M in Q2 2025. 213 funds tracked by Wall St. Rank hold CLVT as of Q3 2025.

  • Axa reported no remaining Clarivate position as of Q3 2025 after selling out during the quarter.
  • Axa sold 271,807 Clarivate shares in Q3 2025, an estimated $1.17M.
  • Axa first reported a position in Clarivate in Q1 2025 and held it in 2 quarters.
  • Axa's Clarivate position peaked at $1.17M in Q2 2025.
  • 213 funds tracked by Wall St. Rank held Clarivate as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.